Advancell Efficacy

Published: 26-Mar-2010
Regulatory

ADVANCELL in vitro systems are of special value to support marketing claims of efficacy and to provide insights into molecular mechanisms at an early stage.

ADVANCELL in vitro systems are of special value to support marketing claims of efficacy and to provide insights into molecular mechanisms at an early stage in the development process, prior to in vivo assessment in human volunteers and as an alternative to animals. Efficacy Claims: anti-aging, anti-oxidant effect, skin inflammation, skin sensitization, vitalizing, firmness, elasticity, moisturizing, skin repair, photoprotection, calmin effect, reconstituted 3D Human tissues, anti-cellulitic activity, in vivo determination in human volunteers.
See more

You may also like

Manufacturing

Advancell and Gentronix to offer genotoxicity screening assays for C&T industry

Read more
New partnership offers GreenScreen HC and BlueScreen HC via contract service

Trending Articles

  1. L’Oréal faces six lawsuits over benzene contamination in acne treatments The US Judicial Panel on Multidistrict Litigation will begin hearings on the lawsuits at the end of the month
  2. How cosmetic labelling mistakes can delay your launch In cosmetic product development, labelling is often treated as a final administrative step — something to be completed once the formula, packaging, and branding are finished. It is a critical regulatory and technical stage that can directly impact whether a product launches on time or is delayed at the last minute
  3. European Commission presents roadmap to phase out animal testing for chemical safety assessments The EU Commission has shared details of a three pillared-approach to phase out animal testing for chemical safety assessments, building on the existing REACH framework
  4. IRI-Sys: Inside the AI Workspace Behind 100,000+ Regulatory Analyses for Beauty and Personal Care In a category where compliance work, formula data, and marketing claims still largely live in spreadsheets, email threads, and disconnected workflows, IRI-Sys has been building something different: an AI workspace for beauty and personal care that helps brands and manufacturers stay compliant, launch fast, and scale globally
  5. A guide on how to write cosmetics ingredient lists in EU, US and Canada Labelling represents an important part of a cosmetic product packaging, from both the regulatory and marketing view

Upcoming event

Anti-Ageing Skin Care Conference

23-24 June 2026 | London, UK See all

You may also like

Manufacturing

Advancell and Gentronix to offer genotoxicity screening assays for C&T industry

New partnership offers GreenScreen HC and BlueScreen HC via contract service
Regulatory

Scientific Advisor

Based on its large expertise in cell culture, molecular biology, toxicity and efficacy studies.
Regulatory

Advancell Irritation & Corrosion Testing

ADVANCELL offers in vitro safety and toxicology services in accordance to OECD Guidelines and ECVAM test procedures.
Regulatory

Advancell Toxicity

ADVANCELL offers in vitro safety and toxicology services in accordance to OECD Guidelines and ECVAM test procedures.
Regulatory

MSL Solution Providers celebrates 25 years of scientific and regulatory excellence

2026 marks 25 years of MSL Solution Providers, one of the UK’s leading microbiological testing and regulatory houses for cosmetics, personal care and household cleansing products
Regulatory

Revolution Beauty investigation closed by UK financial watchdog

Three years after launching a probe into cosmetics company Revolution Beauty, the UK’s Financial Conduct Authority is taking no further action
Regulatory

How cosmetic labelling mistakes can delay your launch

In cosmetic product development, labelling is often treated as a final administrative step — something to be completed once the formula, packaging, and branding are finished. It is a critical regulatory and technical stage that can directly impact whether a product launches on time or is delayed at the last minute
Subscribe now